Photoclinic: Plexiform Neurofibroma

Publication
Article
Consultant for PediatriciansConsultant for Pediatricians Vol 4 No 10
Volume 4
Issue 10

Photoclinic: Plexiform Neurofibroma

Photoclinic: Plexiform Neurofibroma

Articles in this issue
Carbon Monoxide Poisoning: Clues to Unmasking the Great Masquerader
Pediatrics Update: Amblyopia Therapy Is for Older Children Too
Tinea Faciei and Tinea Versicolor
Photoclinic: Hooked Finger
What’s Wrong With This Picture? Child With Fever and Persistent Cough
Photoclinic: Cutaneous Calcinosis in a Child With Tertiary Hyperparathyroidism
Photoclinic: Plexiform Neurofibroma
Pediatrics Update: Avian Flu: Why All the Squawk?
Photoclinic: Perianal Streptococcal Dermatitis
Photoclinic: Bohn Nodules
Photoclinic: Congenital Melanocytic Nevus
Pediatrics Update: "Flu" Season: Here We Go Again . . .
Photoclinic: Adverse Reaction to MMR Immunization
Recent Videos
Lewis Romer, MD
Susan Carnell, PhD
Robert Frenck, MD | Image credit: Cincinnati Children's
Susan Carnell, PhD
Russell Libby, MD, FAAP
Russell Libby, MD, FAAP
Greg Forlenza, MD
Lawrence Eichenfield, MD
Nathan Kuppermann, MD, MPH
COVID-19 Roundtable: Considering off label therapies
Related Content
Robert Frenck, MD

Discussing pediatric vaccination with vaccine-hesitant parents

Joshua Fitch, Senior Editor
January 20th 2025
Article

Robert Frenck, MD, offers several practical tips to use when discussing pediatric vaccination among vaccine-hesitant parents.

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
Weekly review: New neffy PDUFA, crinecerfont discussion for CAH, and more | Image Credit: © Artur - © Artur - stock.adobe.com.

Weekly review: New neffy PDUFA, crinecerfont discussion for CAH, and more

Joshua Fitch, Senior Editor
January 17th 2025
Article

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
Xavier Becerra

HHS expands Medicare drug price negotiations to add 15 medications

Morgan Ebert, Managing Editor
January 17th 2025
Article

HHS selects 15 more Medicare Part D drugs for price negotiation under the Inflation Reduction Act, aiming to lower costs for millions by 2027.

Quick reactions to the FDA banning of FD&C red No. 3 | Image Credit: © John Doe - © John Doe - stock.adobe.com.

Quick reactions to the FDA ban of FD&C red No. 3

Joshua Fitch, Senior Editor
January 16th 2025
Article

Read these quick comments from Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, and Bernard Cohen, MD, regarding the banning of red No. 3 from foods and ingested drugs.

© 2025 MJH Life Sciences

All rights reserved.